Joseph Frattaroli
No más puestos en curso
Fortuna: 15 229 $ al 30/04/2024
Historial de carrera de Joseph Frattaroli
Antiguos cargos conocidos de Joseph Frattaroli.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Director Financiero/CFO | 01/04/2018 | 31/03/2024 |
Vaso Active Pharmaceuticals, Inc.
 Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish. | Director Financiero/CFO | 24/12/2009 | 06/11/2012 |
| Presidente | 01/06/2003 | 06/11/2012 | |
| Flagship Consulting, Inc. | Fundador | 01/01/2010 | - |
Formación de Joseph Frattaroli.
| Salem State University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Director of Finance/CFO | 2 |
| President | 1 |
| Founder | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Vaso Active Pharmaceuticals, Inc.
Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish. | Health Technology |
| Flagship Consulting, Inc. |
- Bolsa de valores
- Insiders
- Joseph Frattaroli
- Experiencia
